These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hyperlipidemia following renal transplantation. Ibels LS, Alfrey AC, Subryan V, Weil R. Trans Am Soc Artif Intern Organs; 1976; 22():46-53. PubMed ID: 781985 [Abstract] [Full Text] [Related]
6. Hyperlipidaemia and post-heparin lipase activities in renal transplant recipients treated with sirolimus or cyclosporin A. Massy ZA, De Bandt JP, Morelon E, Thevenin M, Lacour B, Kreis H. Nephrol Dial Transplant; 2000 Jun; 15(6):928. PubMed ID: 10831671 [No Abstract] [Full Text] [Related]
15. Hyperlipidemia in children with normal allograft function. Derakhshan N, Derakhshan D, Derakhshan A, Hashemi G, Fallahzadeh MH, Basiratnia M, Bazargani Z, Jalaeian H, Malek-Hosseini SA. Saudi J Kidney Dis Transpl; 2011 Mar 28; 22(2):339-40. PubMed ID: 21422639 [No Abstract] [Full Text] [Related]
16. Hyperlipidemia after renal transplantation in children. Saldanha LF, Hurst KS, Amend WJ, Lazarus JM, Lowrie EG, Ingelfinger J, Grupe W, Levey R. Am J Dis Child; 1976 Sep 28; 130(9):951-3. PubMed ID: 786005 [Abstract] [Full Text] [Related]
17. Ezetimibe is effective in the treatment of persistent hyperlipidemia of renal allograft recipients. Savvidaki E, Koukoulaki M, Benou A, Roumeliotou M, Fourtounas C, Kalliakmani P, Papachristou E, Vlachojannis JG, Goumenos D. Clin Nephrol; 2011 Feb 28; 75(2):107-12. PubMed ID: 21255539 [Abstract] [Full Text] [Related]